Sei Investments Co. Acquires 6,681 Shares of Prestige Consumer Healthcare Inc. $PBH

Key Points

• Sei Investments Co. increased its holdings in Prestige Consumer Healthcare Inc. by 3.2% in the first quarter, owning 215,271 shares valued at approximately $17.05 million.
• The company's quarterly earnings report revealed an EPS of $0.95, which was below analysts' expectations of $1.01, and a revenue decline of 6.6% year-over-year.
• Prestige Consumer Healthcare currently holds an average rating of "Hold" from analysts, with a consensus price target of $93.33 per share.

Sei Investments Co. boosted its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 215,271 shares of the company's stock after purchasing an additional 6,681 shares during the period. Sei Investments Co. owned about 0.43% of Prestige Consumer Healthcare worth $17,051,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of PBH. Russell Investments Group Ltd. increased its position in Prestige Consumer Healthcare by 2.0% during the 1st quarter. Russell Investments Group Ltd. now owns 28,115 shares of the company's stock valued at $2,417,000 after purchasing an additional 561 shares during the period. Resona Asset Management Co. Ltd. boosted its stake in shares of Prestige Consumer Healthcare by 2.3% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company's stock valued at $783,000 after purchasing an additional 203 shares in the last quarter. Informed Momentum Co LLC purchased a new position in shares of Prestige Consumer Healthcare during the first quarter valued at about $3,559,000. Public Sector Pension Investment Board raised its stake in Prestige Consumer Healthcare by 44.6% in the first quarter. Public Sector Pension Investment Board now owns 178,019 shares of the company's stock worth $15,304,000 after buying an additional 54,926 shares in the last quarter. Finally, Nuveen LLC purchased a new stake in Prestige Consumer Healthcare in the first quarter worth about $8,323,000. Institutional investors own 99.95% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on PBH shares. Wall Street Zen downgraded Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Canaccord Genuity Group reduced their price target on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Finally, Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Down 0.3%

Shares of NYSE:PBH traded down $0.1860 on Wednesday, hitting $65.2240. 657,471 shares of the company traded hands, compared to its average volume of 549,104. The company has a market cap of $3.21 billion, a PE ratio of 15.31, a PEG ratio of 2.07 and a beta of 0.43. The stock has a 50 day simple moving average of $76.03 and a 200-day simple moving average of $81.31. Prestige Consumer Healthcare Inc. has a 52 week low of $62.95 and a 52 week high of $90.04. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The firm had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm's revenue for the quarter was down 6.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.